Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward

@article{Wolfe2010TreatmentAC,
  title={Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward},
  author={Daniel Wolfe and M Patrizia Carrieri and Donald S. Shepard},
  journal={The Lancet},
  year={2010},
  volume={376},
  pages={355-366}
}
View on Elsevier
unaids.org.cn
419 Citations
Highly Influential Citations
22
Background Citations
147
Methods Citations
5
Results Citations
4

Figures from this paper

419 Citations

Citation Type

Citation Type

HIV Testing, Care, and Treatment Among Women Who Use Drugs From a Global Perspective: Progress and Challenges
TLDR
Future success in enhancing the HIV continuum for women drug users should consider structural and contextual level barriers and promote social, economic, and legal policies that overhaul the many years of discrimination and stigmatization faced by womendrug users worldwide.
Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries
TLDR
In order to be able to monitor the impact of HIV treatment and harm reduction services for PWID on the epidemic, epidemiological data on IDU and harm Reduction service provision to PWID needs to be regularly collected using standardised indicators.
Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed
HIV and risk environment for injecting drug users: the past, present, and future
Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature.
Accessibility and integration of HIV, TB and harm reduction services for people who inject drugs in Portugal: a rapid assessment
TLDR
The assessment documented two models of integrated HIV, TB and drug dependency care for PWID in Porto, Portugal, which facilitates multidisciplinary care but is resource-intensive, limited to a specific location and offers reduced scope for community/home-based care.
Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India
TLDR
To facilitate IDUs gaining access to ART, systemic changes are needed, including steps to make the environment and procedures at government ART centers more IDU-friendly and steps to decrease HIV- and drug use-related stigma and discrimination faced by IDUs from the general public and health-care providers.
HIV prevention, treatment, and care for people who inject drugs.
TLDR
This issue of the Journal presents the first study of mortality among Chinese methadone clients, with 2 key findings: earlier initiation of ART (at CD4+ T-cell counts >300/mm3) among HIV-positive clients was protective against death, and Methadone doses >75 mg/day were protective againstdeath for all clients, regardless of HIV status.
Human rights and access to hepatitis C treatment for people who inject drugs.
Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modeling.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 130 REFERENCES
Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users
TLDR
This small pilot study suggests that health services based on needle exchange may enhance access to HAART among out-of-treatment HIV-infected IDUs and demonstrates that this population can benefit from this therapy with the support of a nontraditional, community-based health intervention.
Antiretroviral therapy in Malaysia: identifying barriers to universal access
TLDR
Increasing and improved access to ART for HIV-infected patients will entail a multipronged strategy that includes the decentralization of clinical care, increased and ongoing training of healthcare workers and support staff, and a comprehensive and intensive effort to reduce stigma and discrimination.
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage
Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union.
  • D. Wolfe
  • Medicine
    The International journal on drug policy
  • 2007
HIV and risk environment for injecting drug users: the past, present, and future
A review of barriers and facilitators of HIV treatment among injection drug users
TLDR
Evidence demonstrates that several under-utilized interventions and novel antiretroviral delivery modalities have helped to greatly address barriers in several settings, and there is sufficient evidence to support immediate scale-up of these programmes.
Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").
TLDR
There is evidence that the coverage of ART among current/former IDUs is proportionally substantially less than other exposure categories, and ongoing monitoring of ART by exposure and population subgroups is critical to ensuring that scale-up is equitable, and that the distribution of ART is transparent.
Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group.
TLDR
Logistic regression showed that, with respect to ex-IDUs and independently of clinical stage, active IDUs, whether or not they were perceived as such by physicians, were threefold more likely not to receive antiretroviral treatment.
Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview.
Impact of HIV Prevention Programs on Drug Users in Malaysia
  • A. Kamarulzaman
  • Medicine, Political Science
    Journal of acquired immune deficiency syndromes
  • 2009
TLDR
Tension between law enforcement and public health persists, as harm reduction exists alongside an overall drug policy that is based on abstinence and zero tolerance, unless there is harmonization of this policy, sustainability and scale-up of harm reduction programs will remain a challenge.
...
1
2
3
4
5
...